John Lewicki
Patrimonio netto: 31 932 $ in data 31/05/2026
Patrimonio netto: 31 932 $ in data 31/05/2026
John A. Lewicki is Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Formerly, Dr. Lewicki was President, Chief Executive Officer & Director at Mereo BioPharma 5, Inc. from 2018 to 2019.
Prior to that, Dr. Lewicki was Principal at Scios, Inc. from 1983 to 2000.
Dr. Lewicki earned a doctorate from the University of California San Diego.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/02/2026 | 464.130 ( 0,06% ) | 31 932 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Direttore Tecnico/Scientifico/R&S | 01/07/2020 |
| Società | Posizione | Fine |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Amministratore Delegato | 23/04/2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale